APA (7th ed.) Citation

RA, M., JW, L., BR, L., LM, G., DE, A., E, H., . . . EM, K. (2019). Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. Journal of clinical immunology, 39(7), 653. https://doi.org/10.1007/s10875-019-00659-8

Chicago Style (17th ed.) Citation

RA, Marsh, et al. "Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT." Journal of Clinical Immunology 39, no. 7 (2019): 653. https://doi.org/10.1007/s10875-019-00659-8.

MLA (9th ed.) Citation

RA, Marsh, et al. "Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT." Journal of Clinical Immunology, vol. 39, no. 7, 2019, p. 653, https://doi.org/10.1007/s10875-019-00659-8.